Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by Solid1 on Feb 24, 2024 5:03am

Germany

Legalization in Germany is a direct hit for
Medipharm Labs now only needs a normal prescription to prescribe cannabis and extracts. The partnership with Stada is finally bearing fruit. It will be interesting to see how sales in Germany will develop 
Comment by unplugged1 on Feb 24, 2024 5:42pm
9th country to legalize! 
Comment by mdjbrown on Feb 25, 2024 10:02am
Solid1, the president of Medipharm agrees with you "This positive change will make it easier for more German pharmacies to provide medical cannabis. @MediPharmLabs has been using its best in class GMP licenses to provide product to Germany for 4 yrs. Looking forward to expanding our business with our great German partners."  
Comment by Solid1 on Feb 26, 2024 4:43am
Yes, I also read the commentary. The drug approvals must now finally follow. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities